# Immunogenicity Assessment for Therapeutic Protein Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/immunogenicity-assessment-for-therapeutic-protein-products/04e181cd-8e84-4961-b3ec-443e161c6965

> FDA guidance document: Immunogenicity Assessment for Therapeutic Protein Products. Issue date: August 14, 2014. Get complete insights and analysis.

---

## Details

- Title: Immunogenicity Assessment for Therapeutic Protein Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2014-08-14
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-0092">FDA-2013-D-0092</a>

## Related Documents

- [E2F Development Safety Update Report](https://www.globalkeysolutions.net/guidances/guidance-document/e2f-development-safety-update-report/fce1434f-a2f0-418e-adf4-9803cbc032bd)
- [Labeling for Biosimilar Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-products-guidance-for-industry/e13343b3-e9e8-436e-9bcc-ec73cae4d41c)
- [Q11 Development and Manufacture of Drug Substances](https://www.globalkeysolutions.net/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411)